EyePoint (EYPT) Operating Leases (2019 - 2026)
EyePoint (EYPT) posted Operating Leases of $20.2 million for Q1 2026, down 2.61% sequentially from $20.8 million in Q4 2025, and down 9.34% YoY from $22.3 million in Q1 2025.
EyePoint (EYPT) Operating Leases (2019 - 2026) Analysis & Trends
EyePoint has reported Operating Leases for 8 years, with the latest figure at $20.2 million in Q1 2026.
- Quarterly Operating Leases fell 9.34% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (down 9.34% YoY) and the FY2025 annual result came in at $20.8 million, down 4.97% from the prior year.
- Operating Leases slipped to $20.2 million in Q1 2026 per EYPT's latest filing, from $20.8 million in the prior quarter.
- Over five years, Operating Leases peaked at $22.3 million in Q1 2025 and troughed at $1.7 million in Q1 2022.
- A 5-year average of $12.7 million and a median of $6.2 million in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2025: Operating Leases dropped 21.87% in 2022, then surged 382.57% in 2025.
- Over 5 years, Operating Leases stood at $6.0 million in 2022, then fell by 18.01% to $4.9 million in 2023, then jumped by 345.54% to $21.9 million in 2024, then fell by 4.97% to $20.8 million in 2025, then decreased by 2.61% to $20.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $20.2 million, $20.8 million, and $21.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.81 Mn |
| Mar 31, 2026 | 20.23 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 21.30 Mn |
| Jun 30, 2025 | 21.82 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 21.86 Mn |
| Sep 30, 2024 | 21.92 Mn |
| Jun 30, 2024 | 22.16 Mn |
| Mar 31, 2024 | 4.62 Mn |
| Dec 31, 2023 | 4.91 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.46 Mn |
| Mar 31, 2023 | 5.72 Mn |
| Dec 31, 2022 | 5.98 Mn |
| Sep 30, 2022 | 6.24 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 2.02 Mn |